Chemotherapy-associated angiogenesis in neuroblastoma tumors

American Journal of Pathology

Volumn 180, Issue 4, 2012, Pages 1370-1377

  Michaelis, Martin ^a   Hinsch, Nora ^a   Michaelis, U Ruth ^a   Rothweiler, Florian ^a   Simon, Thorsten ^b   Ilhelm Doerr, Hans W ^a   Cinatl, Jaroslav ^a   Cinatl Jr , Jindrich ^a  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN KINASE C BETA; VASCULOTROPIN RECEPTOR 2; VINCRISTINE; VITRONECTIN; VITRONECTIN RECEPTOR;

ANGIOGENESIS; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CELL ACTIVATION; CELL VIABILITY; CONCENTRATION RESPONSE; DOSE RESPONSE; ENDOTHELIUM CELL; EVENT FREE SURVIVAL; HUMAN; HUMAN CELL CULTURE; HUMAN TISSUE; IC 50; IN VITRO STUDY; IN VIVO STUDY; MICROVASCULATURE; NEUROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; CISPLATIN; DOXORUBICIN; ENDOTHELIAL CELLS; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; NEUROBLASTOMA; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; VINCRISTINE;

EID: 84859104335     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.12.011     Document Type: Article

References (54)

1. R.S. Kerbel Tumor angiogenesis N Engl J Med 358 2008 2039 2049
2. R.S. Kerbel, B.A. Kamen The anti-angiogenic basis of metronomic chemotherapy Nat Rev Cancer 4 2004 423 436
3. E.S. Kleinerman, L.A. Zwelling, A.V. Muchmore Enhancement of naturally occurring human spontaneous monocyte-mediated cytotoxicity by cis-diamminedichloroplatinum(II) Cancer Res 40 1980 3099 3102
4. A.K. Lichtenstein, D. Pende Enhancement of natural killer cytotoxicity by cis-diamminedichloroplatinum (II) in vivo and in vitro Cancer Res 46 1986 639 644
5. K. Pai, A. Shrivastava, R. Kumar, S. Khetarpal, B. Sarmah, P. Gupta, A. Sodhi Activation of P388D1 macrophage cell line by chemotherapeutic drugs Life Sci 60 1997 1239 1248
6. D.C. Lev, M. Ruiz, L. Mills, E.C. McGary, J.E. Price, M. Bar-Eli Dacarbazine causes transcriptional up-regulation of interleukin 8 and vascular endothelial growth factor in melanoma cells: a possible escape mechanism from chemotherapy Mol Cancer Ther 2 2003 753 763
7. D.C. Lev, A. Onn, V.O. Melinkova, C. Miller, V. Stone, M. Ruiz, E.C. McGary, H.N. Ananthaswamy, J.E. Price, M. Bar-Eli Exposure of melanoma cells to dacarbazine results in enhanced tumor growth and metastasis in vivo J Clin Oncol 22 2004 2092 2100
8. Y. Miyahara, S. Yoshida, S. Motoyama, Y. Tateiwa, S. Hamana, T. Maruo Effect of cis-diammine dichloroplatinum on vascular endothelial growth factor expression in uterine cervical carcinoma Eur J Gynaecol Oncol 25 2004 33 39
9. F. Riedel, K. Gtte, U. Goessler, H. Sadick, K. Hrmann Targeting chemotherapy-induced VEGF up-regulation by VEGF antisense oligonucleotides in HNSCC cell lines Anticancer Res 24 2004 2179 2183
10. V. Levina, Y. Su, B. Nolen, X. Liu, Y. Gordin, M. Lee, A. Lokshin, E. Gorelik Chemotherapeutic drugs and human tumor cells cytokine network Int J Cancer 123 2008 2031 2040
11. G. Ramesh, W. Brian Reeves Cisplatin increases TNF-alpha mRNA stability in kidney proximal tubule cells Ren Fail 28 2006 583 592
12. S. Merighi, C. Simioni, S. Gessi, K. Varani, P. Mirandola, M.A. Tabrizi, P.G. Baraldi, P.A. Borea A(2B) and A(3) adenosine receptors modulate vascular endothelial growth factor and interleukin-8 expression in human melanoma cells treated with etoposide and doxorubicin Neoplasia 11 2009 1064 1073
13. Y. Shaked, A. Ciarrocchi, M. Franco, C.R. Lee, S. Man, A.M. Cheung, D.J. Hicklin, D. Chaplin, F.S. Foster, R. Benezra, R.S. Kerbel Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors Science 313 2006 1785 1787
14. Y. Shaked, E. Henke, J.M. Roodhart, P. Mancuso, M.H. Langenberg, M. Colleoni, L.G. Daenen, S. Man, P. Xu, U. Emmenegger, T. Tang, Z. Zhu, L. Witte, R.M. Strieter, F. Bertolini, E.E. Voest, R. Benezra, R.S. Kerbel Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents Cancer Cell 14 2008 263 273
15. L.A. Gilbert, M.T. Hemann DNA damage-mediated induction of a chemoresistant niche Cell 143 2010 355 366
16. C.C. Chang, O.Z. Lerman, V.D. Thanik, C.L. Scharf, M.R. Greives, R.J. Schneider, S.C. Formenti, P.B. Saadeh, S.M. Warren, J.P. Levine Dose-dependent effect of radiation on angiogenic and angiostatic CXC chemokine expression in human endothelial cells Cytokine 48 2009 295 302
17. I. Sofia Vala, L.R. Martins, N. Imaizumi, R.J. Nunes, J. Rino, F. Kuonen, L.M. Carvalho, C. Regg, I.M. Grillo, J.T. Barata, M. Mareel, S.C. Santos Low doses of ionizing radiation promote tumor growth and metastasis by enhancing angiogenesis PLoS One 5 2010 e11222
18. J.M. Maris, M.D. Hogarty, R. Bagatell, S.L. Cohn Neuroblastoma Lancet 369 2007 2106 2120
19. J. Rssler, M. Taylor, B. Geoerger, F. Farace, J. Lagodny, R. Peschka-Sss, C.M. Niemeyer, G. Vassal Angiogenesis as a target in neuroblastoma Eur J Cancer 44 2008 1645 1656
20. R. Kotchetkov, J. Cinatl, R. Blaheta, J.U. Vogel, J. Karaskova, J. Squire, P. Herniz Driever, T. Klingebiel, J. Cinatl Jr Development of resistance to vincristine and doxorubicin in neuroblastoma alters malignant properties and induces additional karyotype changes: a preclinical model Int J Cancer 104 2003 36 43
21. R. Kotchetkov, P.H. Driever, J. Cinatl, M. Michaelis, J. Karaskova, R. Blaheta, J.A. Squire, A. Von Deimling, J. Moog, J. Cinatl Jr Increased malignant behavior in neuroblastoma cells with acquired multi-drug resistance does not depend on P-gp expression Int J Oncol 27 2005 1029 1037
22. M. Michaelis, J. Cinatl, P. Anand, F. Rothweiler, R. Kotchetkov, A. von Deimling, H.W. Doerr, K. Shogen, J. Cinatl Jr Onconase induces caspase-independent cell death in chemoresistant neuroblastoma cells Cancer Lett 250 2007 107 116
23. M. Michaelis, U.R. Michaelis, I. Fleming, T. Suhan, J. Cinatl, R.A. Blaheta, K. Hoffmann, R. Kotchetkov, R. Busse, H. Nau, J. Cinatl Jr Valproic acid inhibits angiogenesis in vitro and in vivo Mol Pharmacol 65 2004 520 527
24. A.C. Webler, U.R. Michaelis, R. Popp, E. Barbosa-Sicard, A. Murugan, J.R. Falck, B. Fisslthaler, I. Fleming Epoxyeicosatrienoic acids are part of the VEGF-activated signaling cascade leading to angiogenesis Am J Physiol Cell Physiol 295 2008 C1292 C1301
25. L. Jakobsson, C.A. Franco, K. Bentley, R.T. Collins, B. Ponsioen, I.M. Aspalter, I. Rosewell, M. Busse, G. Thurston, A. Medvinsky, S. Schulte-Merker, H. Gerhardt Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting Nat Cell Biol 12 2010 943 953
26. K. Weber, U. Bartsch, C. Stocking, B. Fehse A multicolor panel of novel lentiviral "gene ontology" (LeGO) vectors for functional gene analysis Mol Ther 16 2008 698 706
27. F. Rothweiler, M. Michaelis, P. Brauer, J. Otte, K. Weber, B. Fehse, B. Fehse, H.W. Doerr, M. Wiese, J. Kreuter, Y. Al-Abed, F. Nicoletti, J. Cinatl Jr Anticancer effects of the nitric oxide-modified saquinavir derivative saquinavir-NO against multidrug-resistant cancer cells Neoplasia 12 2010 1023 1030
28. D. Ribatti, B. Nico, A. Vacca, M. Presta The gelatin sponge- chorioallantoic membrane assay Nat Protoc 1 2006 85 91
29. A. Eberhard, S. Kahlert, V. Goede, B. Hemmerlein, K.H. Plate, H.G. Augustin Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies Cancer Res 60 2000 1388 1393
30. P.R. Somanath, N.L. Malinin, T.V. Byzova Cooperation between integrin alphavbeta3 and VEGFR2 in angiogenesis Angiogenesis 12 2009 177 185
31. H. Yoshiji, S. Kuriyama, D.K. Ways, J. Yoshii, Y. Miyamoto, M. Kawata, Y. Ikenaka, H. Tsujinoue, T. Nakatani, M. Shibuya, H. Fukui Protein kinase C lies on the signaling pathway for vascular endothelial growth factor-mediated tumor development and angiogenesis Cancer Res 59 1999 4413 4418
32. I. Zachary VEGF signalling: integration and multi-tasking in endothelial cell biology Biochem Soc Trans 31 2003 1171 1177
33. M. Michaelis, T. Suhan, U.R. Michaelis, K. Beek, F. Rothweiler, L. Tausch, O. Werz, D. Eikel, M. Zrnig, H. Nau, I. Fleming, H.W. Doerr, J. Cinatl Jr Valproic acid induces extracellular signal-regulated kinase 1/2 activation and inhibits apoptosis in endothelial cells Cell Death Differ 13 2006 446 453
34. M. Michaelis, D. Klassert, S. Barth, T. Suhan, R. Breitling, B. Mayer, N. Hinsch, H.W. Doerr, J. Cinatl, J. Cinatl Jr Chemoresistance acquisition induces a global shift of expression of aniogenesis-associated genes and increased pro-angogenic activity in neuroblastoma cells Mol Cancer 8 2009 80
35. F. Berthold, J. Boos, S. Burdach, R. Erttmann, G. Henze, J. Hermann, T. Klingebiel, B. Kremens, F.H. Schilling, M. Schrappe, T. Simon, B. Hero Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial Lancet Oncol 6 2005 649 658
36. F. Morschhauser, J.F. Seymour, H.C. Kluin-Nelemans, A. Grigg, M. Wolf, M. Pfreundschuh, H. Tilly, J. Raemaekers, M.B. van't Veer, N. Milpied, G. Cartron, A. Pezzutto, A. Spencer, F. Reyes, M. Dreyling A phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory mantle cell lymphoma Ann Oncol 19 2008 247 253
37. W. Wick, V.K. Puduvalli, M.C. Chamberlain, M.J. van den Bent, A.F. Carpentier, L.M. Cher, W. Mason, M. Weller, S. Hong, L. Musib, A.M. Liepa, D.E. Thornton, H.A. Fine Phase III study of enzastaurin compared with lomustine in the treatment of recurrent intracranial glioblastoma J Clin Oncol 28 2010 1168 1174
38. A. Brozovic, M. Osmak Activation of mitogen-activated protein kinases by cisplatin and their role in cisplatin-resistance Cancer Lett 251 2007 1 16
39. K. Chatterjee, J. Zhang, N. Honbo, U. Simonis, R. Shaw, J.S. Karliner Acute vincristine pretreatment protects adult mouse cardiac myocytes from oxidative stress J Mol Cell Cardiol 43 2007 327 336
40. M.W. Lee, D.S. Kim, N.Y. Min, H.T. Kim Akt1 inhibition by RNA interference sensitizes human non-small cell lung cancer cells to cisplatin Int J Cancer 122 2008 2380 2384
41. H.G. Yu, Y.W. Ai, L.L. Yu, X.D. Zhou, J. Liu, J.H. Li, X.M. Xu, S. Liu, J. Chen, F. Liu, Y.L. Qi, Q. Deng, J. Cao, S.Q. Liu, H.S. Luo, J.P. Yu Phosphoinositide 3-kinase/Akt pathway plays an important role in chemoresistance of gastric cancer cells against etoposide and doxorubicin induced cell death Int J Cancer 122 2008 433 443
42. L. Jakobsson, K. Bentley, H. Gerhardt VEGFRs and Notch: a dynamic collaboration in vascular patterning Biochem Soc Trans 37 2009 1233 1236
43. T. Kume Novel insights into the differential functions of Notch ligands in vascular formation J Angiogenes Res 1 2009 8
44. L.K. Phng, M. Potente, J.D. Leslie, J. Babbage, D. Nyqvist, I. Lobov, J.K. Ondr, S. Rao, R.A. Lang, G. Thurston, H. Gerhardt Nrarp coordinates endothelial Notch and Wnt signaling to control vessel density in angiogenesis Dev Cell 16 2009 70 82
45. N.S. Patel, J.L. Li, D. Generali, R. Poulsom, D.W. Cranston, A.L. Harris Up-regulation of delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function Cancer Res 65 2005 8690 8697
46. C.K. Williams, J.L. Li, M. Murga, A.L. Harris, G. Tosato Up-regulation of the Notch ligand Delta-like 4 inhibits VEGF-induced endothelial cell function Blood 107 2006 931 939
47. M. Segarra, C.K. Williams, L. Sierra Mde, M. Bernardo, P.J. McCormick, D. Maric, C. Regino, P. Choyke, G. Tosato Dll4 activation of Notch signaling reduces tumor vascularity and inhibits tumor growth Blood 112 2008 1904 1911
48. X. Dong, Y.S. Wang, G.R. Dou, H.Y. Hou, Y.Y. Shi, R. Zhang, K. Ma, L. Wu, L.B. Yao, Y. Cai, J. Zhang Influence of Dll4 via HIF-1α-VEGF signaling on the angiogenesis of choroidal neovascularization under hypoxic conditions PLoS One 6 2011 e18481
49. F. Bussolino, M. Ziche, J.M. Wang, D. Alessi, L. Morbidelli, O. Cremona, A. Bosia, P.C. Marchisio, A. Mantovani In vitro and in vivo activation of endothelial cells by colony-stimulating factors J Clin Invest 87 1991 986 995
50. M. Cotter, C. Gulmann, M. Jeffers, O.P. Smith Increased bone marrow angiogenesis in children with severe chronic neutropenia treated with granulocyte colony-stimulating factor J Pediatr Hematol Oncol 26 2004 504 506
51. T. Voloshin, S. Gingis-Velitski, R. Bril, L. Benayoun, M. Munster, C. Milsom, S. Man, R.S. Kerbel, Y. Shaked G-CSF supplementation with chemotherapy can promote revascularization and subsequent tumor regrowth: prevention by a CXCR4 antagonist Blood 118 2011 3426 3435
52. B.Z. Qian, J.W. Pollard Macrophage diversity enhances tumor progression and metastasis Cell 141 2010 39 51
53. R.K. Jain Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy Science 307 2005 58 62
54. F.E. Escorcia, E. Henke, M.R. McDevitt, C.H. Villa, P. Smith-Jones, R.G. Blasberg, R. Benezra, D.A. Scheinberg Selective killing of tumor neovasculature paradoxically improves chemotherapy delivery to tumors Cancer Res 70 2010 9277 9286